Your browser doesn't support javascript.
loading
Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry.
Kisserli, Aymric; Audonnet, Sandra; Duret, Valérie; Tabary, Thierry; Cohen, Jacques Henri Max; Mahmoudi, Rachid.
Afiliação
  • Kisserli A; Oncogeriatric Coordination Unit, Reims University Hospitals, Maison Blanche Hospital; Faculty of Medicine, University of Reims Champagne-Ardenne.
  • Audonnet S; URCACyt, Flow cytometry technical platform, University of Reims Champagne-Ardenne.
  • Duret V; Faculty of Medicine, University of Reims Champagne-Ardenne; Department of Immunology, Reims University Hospitals, Robert Debre Hospital.
  • Tabary T; Faculty of Medicine, University of Reims Champagne-Ardenne; Department of Immunology, Reims University Hospitals, Robert Debre Hospital.
  • Cohen JHM; Faculty of Medicine, University of Reims Champagne-Ardenne; jhmcohen@gmail.com.
  • Mahmoudi R; Department of Internal Medicine and Geriatrics, Reims University Hospitals, Maison Blanche Hospital; Faculty of Medicine, University of Reims Champagne-Ardenne.
J Vis Exp ; (159)2020 05 19.
Article em En | MEDLINE | ID: mdl-32510517
ABSTRACT
CR1 (CD35, Complement Receptor type 1 for C3b/C4b) is a high molecular weight membrane glycoprotein of about 200 kDa that controls complement activation, transports immune complexes, and participates in humoral and cellular immune responses. CR1 is present on the surface of many cell types, including erythrocytes, and exhibits polymorphisms in length, structure (Knops, or KN, blood group), and density. The average density of CR1 per erythrocyte (CR1/E) is 500 molecules per erythrocyte. This density varies from one individual to another (100-1,200 CR1/E) and from one erythrocyte to another in the same individual. We present here a robust flow cytometry method to measure the density of CR1/E, including in subjects expressing a low density, with the help of an amplifying immunostaining system. This method has enabled us to show the lowering of CR1 erythrocyte expression in diseases such as Alzheimer's disease (AD), systemic lupus erythematosus (SLE), AIDS, or malaria.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Receptores de Complemento / Eritrócitos / Citometria de Fluxo Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: J Vis Exp Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Receptores de Complemento / Eritrócitos / Citometria de Fluxo Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: J Vis Exp Ano de publicação: 2020 Tipo de documento: Article